We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Closure Device Prevents Injuries

By HospiMedica staff writers
Posted on 25 Oct 2005
A new closure device is designed to prevent suture needlestick injuries to surgeons and operating room (OR) staff.

The most common cause of suture needlestick injury is fascia closure, closure of the underlying layer below the skin that must be closed at the conclusion of most major surgical procedures. More...
This accounts for 59% of all reported sharps injuries in the OR.

The 360o Fascia Closure Device has been cleared by the U.S. Food and Drug Administration (FDA). The patented device protects against suture needlestick injuries by ensuring that the sharp point of the suture needle--contained within a sterile, disposable suture cartridge at all times--is never exposed. Therefore, hands and fingers are not exposed to the sharp point of the needle before, during, or after the procedure. Closure is faster, easier, and safer for surgeons than tedious and difficult hand-suturing. The closure device is the product of SuturTek (North Chelmsford, MA, USA).

The Fascia Closure Device has been used in a wide variety of surgical procedures in the United States and Europe, including abdominal surgeries, cesarian deliveries, abdominal hysterectomies, and spinal surgery.

"The critical importance of our 360o Fascia Closure Device, that protects surgeons, nurses, and OR staff against needlesticks, is underscored by a recent study from Johns Hopkins [Baltimore, MD, USA] reporting that almost 40% of urban surgery patients are infected with deadly diseases such as hepatitis or HIV/AIDS,” noted Gerald Brecher, president and CEO of SuturTek. "And surgeons tell us that our device is not only safe, but it's also fast, easy to use, and delivers high quality clinical results.”





Related Links:
SuturTek

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.